Anti-TAU Antibody / MAPT
MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
Product Specifications
CAS Number
9007-83-4
Specifications
Western blot: 1:1000, IHC (Paraffin) : 1:10-1:50
UniProt
P10636
Host
Rabbit
Reactivity
Human
Immunogen
A portion of amino acids 699-728 from the human protein was used as the immunogen for this anti-TAU antibody.
Clonality
Polyclonal
Isotype
Ig
Applications
IHC, WB, ELISA
Purity
Antigen affinity
Format
Antigen affinity purified
Buffer
In 1X PBS pH 7.4 with 0.09% sodium azide
Reconstitution
Aliquot the anti-TAU antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitations
This anti-TAU antibody is available for research use only.
Storage Conditions
Aliquot the anti-TAU antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
In 1X PBS, pH 7.4, with 0.09% sodium azide
Applications Notes
Titration of the anti-TAU antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Prediction Reactivity
Mouse, Rat, Bovine
Image Legend
Anti-TAU antibody western blot analysis in SH-SY5Y lysate. Expected molecular weight: 50-80 kDa.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ATP13A2 Polyclonal Antibody, Cy5.5 Conjugated
